Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Biologic Drugs Market By Therapeutic Protein, Monoclonal Antibody and Vaccine - Global Industry Analysis And Forecast To 2025

  • CRY2872011
  • 170 Pages
  • December 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
Biologic Drugs Market By Therapeutic Protein (Betaseron, Levemir, Aranesp, Humalog, Neulasta, Epogen, Neupogen, Eylea, Avonex, Rebif, Enbrel, Victoza, Lantus and NovoLog); Monoclonal Antibody (Remicade, Humira, Avastin, Lucentis, Herceptin and Rituxan) and Vaccine (Varivax, Fluzone, Gardasil, Cervarix and Prenvar 13) - Global Industry Analysis And Forecast To 2025

Industry Outlook

Biologic Drugs are the drugs made up of complex molecules produced from the living microorganisms, plants or animal cells. Numbers of Biologic Drugs are manufactured using recombinant DNA technique. They are sometimes referred to as Biopharmaceuticals. Biologic Drugs are a revolutionized way of treatment for many serious and prolonged diseases, they have pushed down the small-molecule drugs from top rank. Disorders like Rheumatoid arthritis, certain cancers, and diabetes have more number of Biologic treatments. Biologic Drugs use is growing due to factors like; headway in biomedical science and advancement in novel biological products, rising use of Biologic Drugs in treatment of various disorders, rise in the number of aged people, increasing spread og knowledge about Biologic Drugs by different private and public organizations, technical development & increase in on-going R&D, etc. Therefore, the Biologic Drugs Market is anticipated to expand and has tremendous scope during the forecast period. The global Biologic Drugs Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Biologic Drugs Market is based on segment, by Therapeutic Protein the market is segmented into Betaseron, Levemir, Aranesp, Humalog, Neulasta, Epogen, Neupogen, Eylea, Avonex, Rebif, Enbrel, Victoza, Lantus and NovoLog; by Monoclonal Antibody the market is segmented into Remicade, Humira, Avastin, Lucentis, Herceptin and Rituxan; and by Vaccine the market is segmented into Varivax, Fluzone, Gardasil, Cervarix and Prenvar 13.

Biologic Drugs Market, By Therapeutic Protein

Betaseron

Levemir

Aranesp

Humalog

Neulasta

Epogen

Neupogen

Eylea

Avonex

Rebif

Enbrel

Victoza

Lantus

NovoLog

Biologic Drugs Market, By Monoclonal Antibody

Remicade

Humira

Avastin

Lucentis

Herceptin

Rituxan

Biologic Drugs Market, By Vaccine

Varivax

Fluzone

Gardasil

Cervarix

Prenvar 13

Regional Insights

On a global front, the Biologic Drugs Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the global Biologic Drugs Market.

Biologic Drugs Market, By Region

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Russia

Italy

Rest of Europe

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Rest of Asia-Pacific

South America

Brazil

Argentina

Columbia

Rest of South America

Middle East and Africa

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Rest of MEA

Competitive Analysis

The leading players in the market are Abbott Laboratories, Pfizer Inc., GlaxoSmithKline Plc., Bristol-Myers Squibb Co., Biogen Idec, Eli Lilly and Co., Merck & Co. Inc., Novartis AG, Amgen Inc. and Baxter International Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

Abbott Laboratories

Pfizer Inc.

GlaxoSmithKline Plc.

Bristol-Myers Squibb Co.

Biogen Idec

Eli Lilly and Co.

Merck & Co. Inc.

Novartis AG

Amgen Inc.

Baxter International Inc.

Some of the key questions answered by the report are:

What was the market size in 2014 and forecast from 2015 to 2025?

What will be the industry market growth from 2015 to 2025?

What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?

What are the major segments leading the market growth and why?

Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Table of Contents:

1. Introduction

1.1. Report Description

2. Executive Summary

2.1. Key Highlights

3. Market Overview

3.1. Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. SWOT Analysis

4. Market Analysis by Regions

4.1. North America (United States, Canada and Mexico)

4.1.1. United States Market Status and Outlook (2014-2025)

4.1.2. Canada Market Status and Outlook (2014-2025)

4.1.3. Mexico Market Status and Outlook (2014-2025)

4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1. Germany Market Status and Outlook (2014-2025)

4.2.2. France Market Status and Outlook (2014-2025)

4.2.3. UK Market Status and Outlook (2014-2025)

4.2.4. Russia Market Status and Outlook (2014-2025)

4.2.5. Italy Market Status and Outlook (2014-2025)

4.2.6. Rest of Europe Market Status and Outlook (2014-2025)

4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1. China Market Status and Outlook (2014-2025)

4.3.2. Japan Market Status and Outlook (2014-2025)

4.3.3. Korea Market Status and Outlook (2014-2025)

4.3.4. India Market Status and Outlook (2014-2025)

4.3.5. Southeast Asia Market Status and Outlook (2014-2025)

4.3.6. Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4. South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1. Brazil Market Status and Outlook (2014-2025)

4.4.2. Argentina Market Status and Outlook (2014-2025)

4.4.3. Columbia Market Status and Outlook (2014-2025)

4.4.4. Rest of South America Market Status and Outlook (2014-2025)

4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1. Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2. United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3. Egypt Market Status and Outlook (2014-2025)

4.5.4. Nigeria Market Status and Outlook (2014-2025)

4.5.5. South Africa Market Status and Outlook (2014-2025)

4.5.6. Turkey Market Status and Outlook (2014-2025)

4.5.7. Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5. Biologic Drugs Market, By Therapeutic Protein

5.1. Introduction

5.2. Global Biologic Drugs Revenue and Market Share by Therapeutic Protein (2014-2018)

5.2.1. Global Biologic Drugs Revenue and Revenue Share by Therapeutic Protein (2014-2018)

5.3. Betaseron

5.3.1. Global Betaseron Revenue and Growth Rate (2014-2018)

5.4. Levemir

5.4.1. Global Levemir Revenue and Growth Rate (2014-2018)

5.5. Aranesp

5.5.1. Global Aranesp Revenue and Growth Rate (2014-2018)

5.6. Humalog

5.6.1. Global Humalog Revenue and Growth Rate (2014-2018)

5.7. Neulasta

5.7.1. Global Neulasta Revenue and Growth Rate (2014-2018)

5.8. Epogen

5.8.1. Global Epogen Revenue and Growth Rate (2014-2018)

5.9. Neupogen

5.9.1. Global Neupogen Revenue and Growth Rate (2014-2018)

5.10. Eylea

5.10.1. Global Eylea Revenue and Growth Rate (2014-2018)

5.11. Avonex

5.11.1. Global Avonex Revenue and Growth Rate (2014-2018)

5.12. Rebif

5.12.1. Global Rebif Revenue and Growth Rate (2014-2018)

5.13. Enbrel

5.13.1. Global Enbrel Revenue and Growth Rate (2014-2018)

5.14. Victoza

5.14.1. Global Victoza Revenue and Growth Rate (2014-2018)

5.15. Lantus

5.15.1. Global Lantus Revenue and Growth Rate (2014-2018)

5.16. NovoLog

5.16.1. Global NovoLog Revenue and Growth Rate (2014-2018)

6. Biologic Drugs Market, By Monoclonal Antibody

6.1. Introduction

6.2. Global Biologic Drugs Revenue and Market Share by Monoclonal Antibody (2014-2018)

6.2.1. Global Biologic Drugs Revenue and Revenue Share by Monoclonal Antibody (2014-2018)

6.3. Remicade

6.3.1. Global Remicade Revenue and Growth Rate (2014-2018)

6.4. Humira

6.4.1. Global Humira Revenue and Growth Rate (2014-2018)

6.5. Avastin

6.5.1. Global Avastin Revenue and Growth Rate (2014-2018)

6.6. Lucentis

6.6.1. Global Lucentis Revenue and Growth Rate (2014-2018)

6.7. Herceptin

6.7.1. Global Herceptin Revenue and Growth Rate (2014-2018)

6.8. Rituxan

6.8.1. Global Rituxan Revenue and Growth Rate (2014-2018)

7. Biologic Drugs Market, By Vaccine

7.1. Introduction

7.2. Global Biologic Drugs Revenue and Market Share by Vaccine (2014-2018)

7.2.1. Global Biologic Drugs Revenue and Revenue Share by Vaccine (2014-2018)

7.3. Varivax

7.3.1. Global Varivax Revenue and Growth Rate (2014-2018)

7.4. Fluzone

7.4.1. Global Fluzone Revenue and Growth Rate (2014-2018)

7.5. Gardasil

7.5.1. Global Gardasil Revenue and Growth Rate (2014-2018)

7.6. Cervarix

7.6.1. Global Cervarix Revenue and Growth Rate (2014-2018)

7.7. Prenvar 13

7.7.1. Global Prenvar 13 Revenue and Growth Rate (2014-2018)

8. Biologic Drugs Market, By Region

8.1. Introduction

8.2. Global Biologic Drugs Revenue and Market Share by Regions

8.2.1. Global Biologic Drugs Revenue by Regions (2014-2018)

8.3. North America Biologic Drugs by Countries

8.3.1. North America Biologic Drugs Revenue and Growth Rate (2014-2018)

8.3.2. North America Biologic Drugs Revenue (Million USD) by Countries (2014-2018)

8.3.3. United States

8.3.3.1. United States Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.4. Canada

8.3.4.1. Canada Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.5. Mexico

8.3.5.1. Mexico Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4. Europe Biologic Drugs by Countries

8.4.1. Europe Biologic Drugs Revenue and Growth Rate (2014-2018)

8.4.2. Europe Biologic Drugs Revenue (Million USD) by Countries (2014-2018)

8.4.3. Germany

8.4.3.1. Germany Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.4. France

8.4.4.1. France Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.5. UK

8.4.5.1. UK Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.6. Russia

8.4.6.1. Russia Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.7. Italy

8.4.7.1. Italy Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.8. Rest of Europe

8.4.8.1. Rest of Europe Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5. Asia-Pacific Biologic Drugs by Countries

8.5.1. Asia-Pacific Biologic Drugs Revenue and Growth Rate (2014-2018)

8.5.2. Asia-Pacific Biologic Drugs Revenue (Million USD) by Countries (2014-2018)

8.5.3. China

8.5.3.1. China Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.4. Japan

8.5.4.1. Japan Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.5. Korea

8.5.5.1. Korea Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.6. India

8.5.6.1. India Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.7. Southeast Asia

8.5.7.1. Southeast Asia Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.8. Rest of Asia-Pacific

8.5.8.1. Rest of Asia-Pacific Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.6. South America Biologic Drugs by Countries

8.6.1. South America Biologic Drugs Revenue and Growth Rate (2014-2018)

8.6.2. South America Biologic Drugs Revenue (Million USD) by Countries (2014-2018)

8.6.3. Brazil

8.6.3.1. Brazil Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.4. Argentina

8.6.4.1. Argentina Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.5. Columbia

8.6.5.1. Columbia Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.6. Rest of South America

8.6.6.1. Rest of South America Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7. Middle East and Africa Biologic Drugs by Countries

8.7.1. Middle East and Africa Biologic Drugs Revenue and Growth Rate (2014-2018)

8.7.2. Middle East and Africa Biologic Drugs Revenue (Million USD) by Countries (2014-2018)

8.7.3. Saudi Arabia

8.7.3.1. Saudi Arabia Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.4. United Arab Emirates

8.7.4.1. United Arab Emirates Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.5. Egypt

8.7.5.1. Egypt Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.6. Nigeria

8.7.6.1. Nigeria Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.7. South Africa

8.7.7.1. South Africa Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.8. Turkey

8.7.8.1. Turkey Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.9. Rest of Middle East and Africa

8.7.9.1. Rest of Middle East and Africa Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

9. Company Profiles

9.1. Abbott Laboratories

9.1.1. Business Overview

9.1.2. Service Portfolio

9.1.3. Strategic Developments

9.1.4. Revenue and Market Share

9.2. Pfizer Inc.

9.2.1. Business Overview

9.2.2. Service Portfolio

9.2.3. Strategic Developments

9.2.4. Revenue and Market Share

9.3. GlaxoSmithKline Plc.

9.3.1. Business Overview

9.3.2. Service Portfolio

9.3.3. Strategic Developments

9.3.4. Revenue and Market Share

9.4. Bristol-Myers Squibb Co.

9.4.1. Business Overview

9.4.2. Service Portfolio

9.4.3. Strategic Developments

9.4.4. Revenue and Market Share

9.5. Biogen Idec

9.5.1. Business Overview

9.5.2. Service Portfolio

9.5.3. Strategic Developments

9.5.4. Revenue and Market Share

9.6. Eli Lilly and Co.

9.6.1. Business Overview

9.6.2. Service Portfolio

9.6.3. Strategic Developments

9.6.4. Revenue and Market Share

9.7. Merck & Co. Inc.

9.7.1. Business Overview

9.7.2. Service Portfolio

9.7.3. Strategic Developments

9.7.4. Revenue and Market Share

9.8. Novartis AG

9.8.1. Business Overview

9.8.2. Service Portfolio

9.8.3. Strategic Developments

9.8.4. Revenue and Market Share

9.9. Amgen Inc.

9.9.1. Business Overview

9.9.2. Service Portfolio

9.9.3. Strategic Developments

9.9.4. Revenue and Market Share

9.10. Baxter International Inc.

9.10.1. Business Overview

9.10.2. Service Portfolio

9.10.3. Strategic Developments

9.10.4. Revenue and Market Share

10. Global Biologic Drugs Market Competition, by Manufacturer

10.1. Global Biologic Drugs Revenue and Market Share by Manufacturer (2016-2017)

10.2. Global Biologic Drugs Price By Region (2016-2017)

10.3. Top 5 Biologic Drugs Manufacturer Market Share

10.4. Market Competition Trend

11. Biologic Drugs Market Forecast (2018-2025)

11.1. Global Biologic Drugs Revenue (Millions USD) and Growth Rate (2018-2025)

11.2. Biologic Drugs Market Forecast by Regions (2018-2025)

11.2.1. North America Biologic Drugs Market Forecast (2018-2025)

11.2.1.1. United States Biologic Drugs Market Forecast (2018-2025)

11.2.1.2. Canada Biologic Drugs Market Forecast (2018-2025)

11.2.1.3. Mexico Biologic Drugs Market Forecast (2018-2025)

11.2.2. Europe Biologic Drugs Market Forecast (2018-2025)

11.2.2.1. Germany Biologic Drugs Market Forecast (2018-2025)

11.2.2.2. France Biologic Drugs Market Forecast (2018-2025)

11.2.2.3. UK Biologic Drugs Market Forecast (2018-2025)

11.2.2.4. Russia Biologic Drugs Market Forecast (2018-2025)

11.2.2.5. Italy Biologic Drugs Market Forecast (2018-2025)

11.2.2.6. Rest of Europe Biologic Drugs Market Forecast (2018-2025)

11.2.3. Asia-Pacific Biologic Drugs Market Forecast (2018-2025)

11.2.3.1. China Biologic Drugs Market Forecast (2018-2025)

11.2.3.2. Japan Biologic Drugs Market Forecast (2018-2025)

11.2.3.3. Korea Biologic Drugs Market Forecast (2018-2025)

11.2.3.4. India Biologic Drugs Market Forecast (2018-2025)

11.2.3.5. Southeast Asia Biologic Drugs Market Forecast (2018-2025)

11.2.3.6. Rest of Asia-Pacific Biologic Drugs Market Forecast (2018-2025)

11.2.4. South America Biologic Drugs Market Forecast (2018-2025)

11.2.4.1. Brazil Biologic Drugs Market Forecast (2018-2025)

11.2.4.2. Argentina Biologic Drugs Market Forecast (2018-2025)

11.2.4.3. Columbia Biologic Drugs Market Forecast (2018-2025)

11.2.4.4. Rest of South America Biologic Drugs Market Forecast (2018-2025)

11.2.5. Middle East and Africa Biologic Drugs Market Forecast (2018-2025)

11.2.5.1. Saudi Arabia Biologic Drugs Market Forecast (2018-2025)

11.2.5.2. United Arab Emirates Biologic Drugs Market Forecast (2018-2025)

11.2.5.3. Egypt Biologic Drugs Market Forecast (2018-2025)

11.2.5.4. Nigeria Biologic Drugs Market Forecast (2018-2025)

11.2.5.5. South Africa Biologic Drugs Market Forecast (2018-2025)

11.2.5.6. Turkey Biologic Drugs Market Forecast (2018-2025)

11.2.5.7. Rest of Middle East and Africa Biologic Drugs Market Forecast (2018-2025)

11.3. Biologic Drugs Market Forecast by Therapeutic Protein (2018-2025)

11.3.1. Biologic Drugs Forecast by Therapeutic Protein (2018-2025)

11.3.2. Biologic Drugs Market Share Forecast by Therapeutic Protein (2018-2025)

11.4. Biologic Drugs Market Forecast by Monoclonal Antibody (2018-2025)

11.4.1. Biologic Drugs Forecast by Monoclonal Antibody (2018-2025)

11.4.2. Biologic Drugs Market Share Forecast by Monoclonal Antibody (2018-2025)

11.5. Biologic Drugs Market Forecast by Vaccine (2018-2025)

11.5.1. Biologic Drugs Forecast by Vaccine (2018-2025)

11.5.2. Biologic Drugs Market Share Forecast by Vaccine (2018-2025)

List of Tables and Figures:

Figure United States Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Canada Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Mexico Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Germany Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure France Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure UK Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Russia Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Italy Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of Europe Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure China Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Japan Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Korea Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure India Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Southeast Asia Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of Asia-Pacific Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Brazil Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Argentina Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Columbia Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of South America Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Saudi Arabia Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure United Arab Emirates Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Egypt Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Nigeria Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure South Africa Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Turkey Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of Middle East and Africa Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)

Table Global Biologic Drugs Revenue and Revenue Share by Therapeutic Protein (2014-2018)

Figure Global Betaseron Revenue and Growth Rate (2014-2018)

Figure Global Levemir Revenue and Growth Rate (2014-2018)

Figure Global Aranesp Revenue and Growth Rate (2014-2018)

Figure Global Humalog Revenue and Growth Rate (2014-2018)

Figure Global Neulasta Revenue and Growth Rate (2014-2018)

Figure Global Epogen Revenue and Growth Rate (2014-2018)

Figure Global Neupogen Revenue and Growth Rate (2014-2018)

Figure Global Eylea Revenue and Growth Rate (2014-2018)

Figure Global Avonex Revenue and Growth Rate (2014-2018)

Figure Global Rebif Revenue and Growth Rate (2014-2018)

Figure Global Enbrel Revenue and Growth Rate (2014-2018)

Figure Global Victoza Revenue and Growth Rate (2014-2018)

Figure Global Lantus Revenue and Growth Rate (2014-2018)

Figure Global NovoLog Revenue and Growth Rate (2014-2018)

Table Global Biologic Drugs Revenue and Revenue Share by Monoclonal Antibody (2014-2018)

Figure Global Remicade Revenue and Growth Rate (2014-2018)

Figure Global Humira Revenue and Growth Rate (2014-2018)

Figure Global Avastin Revenue and Growth Rate (2014-2018)

Figure Global Lucentis Revenue and Growth Rate (2014-2018)

Figure Global Herceptin Revenue and Growth Rate (2014-2018)

Figure Global Rituxan Revenue and Growth Rate (2014-2018)

Table Global Biologic Drugs Revenue and Revenue Share by Vaccine (2014-2018)

Figure Global Varivax Revenue and Growth Rate (2014-2018)

Figure Global Fluzone Revenue and Growth Rate (2014-2018)

Figure Global Gardasil Revenue and Growth Rate (2014-2018)

Figure Global Cervarix Revenue and Growth Rate (2014-2018)

Figure Global Prenvar 13 Revenue and Growth Rate (2014-2018)

Table Global Biologic Drugs Revenue by Regions (2014-2018)

Figure North America Biologic Drugs Growth Rate (2014-2018)

Figure North America Biologic Drugs Revenue and Growth Rate (2014-2018)

Figure North America Biologic Drugs by Countries (2014-2018)

Figure North America Biologic Drugs Revenue (Million USD) by Countries (2014-2018)

Figure United States Biologic Drugs Growth Rate (2014-2018)

Figure United States Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Canada Biologic Drugs Growth Rate (2014-2018)

Figure Canada Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Mexico Biologic Drugs Growth Rate (2014-2018)

Figure Mexico Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Europe Biologic Drugs Growth Rate (2014-2018)

Figure Europe Biologic Drugs Revenue and Growth Rate (2014-2018)

Figure Europe Biologic Drugs by Countries (2014-2018)

Figure Europe Biologic Drugs Revenue (Million USD) by Countries (2014-2018)

Figure Germany Biologic Drugs Growth Rate (2014-2018)

Figure Germany Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure France Biologic Drugs Growth Rate (2014-2018)

Figure France Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure UK Biologic Drugs Growth Rate (2014-2018)

Figure UK Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Russia Biologic Drugs Growth Rate (2014-2018)

Figure Russia Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Italy Biologic Drugs Growth Rate (2014-2018)

Figure Italy Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of Europe Biologic Drugs Growth Rate (2014-2018)

Figure Rest of Europe Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Asia-Pacific Biologic Drugs Growth Rate (2014-2018)

Figure Asia-Pacific Biologic Drugs Revenue and Growth Rate (2014-2018)

Figure Asia-Pacific Biologic Drugs by Countries (2014-2018)

Figure Asia-Pacific Biologic Drugs Revenue (Million USD) by Countries (2014-2018)

Figure China Biologic Drugs Growth Rate (2014-2018)

Figure China Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Japan Biologic Drugs Growth Rate (2014-2018)

Figure Japan Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Korea Biologic Drugs Growth Rate (2014-2018)

Figure Korea Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure India Biologic Drugs Growth Rate (2014-2018)

Figure India Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Southeast Asia Biologic Drugs Growth Rate (2014-2018)

Figure Southeast Asia Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of Asia-Pacific Biologic Drugs Growth Rate (2014-2018)

Figure Rest of Asia-Pacific Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure South America Biologic Drugs Growth Rate (2014-2018)

Figure South America Biologic Drugs Revenue and Growth Rate (2014-2018)

Figure South America Biologic Drugs by Countries (2014-2018)

Figure South America Biologic Drugs Revenue (Million USD) by Countries (2014-2018)

Figure Brazil Biologic Drugs Growth Rate (2014-2018)

Figure Brazil Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Argentina Biologic Drugs Growth Rate (2014-2018)

Figure Argentina Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Columbia Biologic Drugs Growth Rate (2014-2018)

Figure Columbia Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of South America Biologic Drugs Growth Rate (2014-2018)

Figure Rest of South America Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Middle East and Africa Biologic Drugs Growth Rate (2014-2018)

Figure Middle East and Africa Biologic Drugs Revenue and Growth Rate (2014-2018)

Figure Middle East and Africa Biologic Drugs by Countries (2014-2018)

Figure Middle East and Africa Biologic Drugs Revenue (Million USD) by Countries (2014-2018)

Figure Saudi Arabia Biologic Drugs Growth Rate (2014-2018)

Figure Saudi Arabia Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure United Arab Emirates Biologic Drugs Growth Rate (2014-2018)

Figure United Arab Emirates Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Egypt Biologic Drugs Growth Rate (2014-2018)

Figure Egypt Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Nigeria Biologic Drugs Growth Rate (2014-2018)

Figure Nigeria Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure South Africa Biologic Drugs Growth Rate (2014-2018)

Figure South Africa Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Turkey Biologic Drugs Growth Rate (2014-2018)

Figure Turkey Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of Middle East and Africa Biologic Drugs Growth Rate (2014-2018)

Figure Rest of Middle East and Africa Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

Table Abbott Laboratories Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Inc. Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Plc. Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bristol-Myers Squibb Co. Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Biogen Idec Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Eli Lilly and Co. Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck & Co. Inc. Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis AG Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Amgen Inc. Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Baxter International Inc. Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Biologic Drugs Market Share by Manufacturer

Figure Global Biologic Drugs Revenue and Market Share by Manufacturer

Table Global Biologic Drugs Price by Region (2016-2017)

Figure Top 5 Biologic Drugs Manufacturer (Revenue) Market Share

Figure Market Competition Trend

Figure Global Biologic Drugs Revenue (Millions USD) and Growth Rate (2018-2025)

Table Biologic Drugs Market Forecast by Regions (2018-2025)

Figure North America Biologic Drugs Market Forecast (2018-2025)

Figure United States Biologic Drugs Market Forecast (2018-2025)

Figure Canada Biologic Drugs Market Forecast (2018-2025)

Figure Mexico Biologic Drugs Market Forecast (2018-2025)

Figure Europe Biologic Drugs Market Forecast (2018-2025)

Figure Germany Biologic Drugs Market Forecast (2018-2025)

Figure France Biologic Drugs Market Forecast (2018-2025)

Figure UK Biologic Drugs Market Forecast (2018-2025)

Figure Russia Biologic Drugs Market Forecast (2018-2025)

Figure Italy Biologic Drugs Market Forecast (2018-2025)

Figure Rest of Europe Biologic Drugs Market Forecast (2018-2025)

Figure Asia-Pacific Biologic Drugs Market Forecast (2018-2025)

Figure China Biologic Drugs Market Forecast (2018-2025)

Figure Japan Biologic Drugs Market Forecast (2018-2025)

Figure Korea Biologic Drugs Market Forecast (2018-2025)

Figure India Biologic Drugs Market Forecast (2018-2025)

Figure Southeast Asia Biologic Drugs Market Forecast (2018-2025)

Figure Rest of Asia-Pacific Biologic Drugs Market Forecast (2018-2025)

Figure South America Biologic Drugs Market Forecast (2018-2025)

Figure Brazil Biologic Drugs Market Forecast (2018-2025)

Figure Argentina Biologic Drugs Market Forecast (2018-2025)

Figure Columbia Biologic Drugs Market Forecast (2018-2025)

Figure Rest of South America Biologic Drugs Market Forecast (2018-2025)

Figure Middle East and Africa Biologic Drugs Market Forecast (2018-2025)

Figure Saudi Arabia Biologic Drugs Market Forecast (2018-2025)

Figure United Arab Emirates Biologic Drugs Market Forecast (2018-2025)

Figure Egypt Biologic Drugs Market Forecast (2018-2025)

Figure Nigeria Biologic Drugs Market Forecast (2018-2025)

Figure South Africa Biologic Drugs Market Forecast (2018-2025)

Figure Turkey Biologic Drugs Market Forecast (2018-2025)

Figure Rest of Middle East and Africa Biologic Drugs Market Forecast (2018-2025)

Figure Global Biologic Drugs Forecast by Therapeutic Protein (2018-2025)

Figure Global Biologic Drugs Market Share Forecast by Therapeutic Protein (2018-2025)

Figure Global Biologic Drugs Forecast by Therapeutic Protein (2018-2025)

Figure Global Biologic Drugs Forecast by Monoclonal Antibody (2018-2025)

Figure Global Biologic Drugs Market Share Forecast by Monoclonal Antibody (2018-2025)

Figure Global Biologic Drugs Forecast by Monoclonal Antibody (2018-2025)

Figure Global Biologic Drugs Forecast by Vaccine (2018-2025)

Figure Global Biologic Drugs Market Share Forecast by Vaccine (2018-2025)

Figure Global Biologic Drugs Forecast by Vaccine (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
View Details
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370
View Details
Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research